Category: cell immunotherapy

  • Patient-to-Patient Supply for Cell Immunotherapies Summit

    Achieving Standardization & Operational Excellence in Vein-to-Vein Supply As an increasing number of candidates enter the clinic and promise to be a mainstay in the future of cancer treatment, cell therapies pose unique supply chain challenges. From temperature and time sensitivity, to patient-facing delivery and chain of identity, these supply chain challenges must be overcome […]